erythritolWhat was measured
Measured, with no finding
754 endpoints
Show what was measuredHide what was measured
A. actinomycetemcomitans (AA) study sites >100,000 cells/ml
no effect
AA >1000; >100,000 | 7; 1 | 7; 0 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
A. actinomycetemcomitans (AA) study sites >100,000 cells/ml
no effect
AA >1000; >100,000 | 3; 0 | 10; 2 | 0.035; n.s.
PMID 25041441 · one of two readings recorded this
A. actinomycetemcomitans (AA) study sites >1000 cells/ml
no effect
AA >1000; >100,000 | 7; 1 | 7; 0 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
A. actinomycetemcomitans (AA) study sites >1000 cells/ml
decreases, p = 0.035
AA >1000; >100,000 | 3; 0 | 10; 2 | 0.035; n.s.
PMID 25041441 · one of two readings recorded this
B. forsythia (BF) study sites >100,000 cells/ml
no effect
BF >1000; >100,000 | 37; 20 | 39; 15 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
B. forsythia (BF) study sites >100,000 cells/ml
no effect
BF >1000; >100,000 | 35; 18 | 35; 19 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
B. forsythia (BF) study sites >1000 cells/ml
no effect
BF >1000; >100,000 | 37; 20 | 39; 15 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
B. forsythia (BF) study sites >1000 cells/ml
no effect
BF >1000; >100,000 | 35; 18 | 35; 19 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
bleeding on probing (BOP+), deepest study site
no effect
BOP+, % | 58 (50) | 48 (50) | n.s.
PMID 25041441 · one of two readings recorded this
bleeding on probing (BOP+), deepest study site
no effect
BOP+, % | 31 (47) | 27 (45) | n.s.
PMID 25041441 · one of two readings recorded this
bleeding on probing (BOP+)
no effect
BOP+, % | 22 (10) | 21 (10) | n.s.
PMID 25041441 · one of two readings recorded this
bleeding on probing (BOP+)
no effect
BOP+, % | 15 (6) | 14 (6) | n.s.
PMID 25041441 · one of two readings recorded this
gingival recession (REC), deepest study site
no effect
REC, mm | 1.0 (0.9) | 0.9 (1.0) | n.s.
PMID 25041441 · one of two readings recorded this
gingival recession (REC), deepest study site
no effect
REC, mm | 1.0 (1.0) | 0.8 (1.1) | n.s.
PMID 25041441 · one of two readings recorded this
gingival recession (REC)
no effect
REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s.
PMID 25041441 · one of two readings recorded this
gingival recession (REC)
no effect
REC, mm | 0.9 (0.7) | 0.9 (0.7) | n.s.
PMID 25041441 · one of two readings recorded this
number of residual pockets with PD >4 mm per subject at 12 months, primary endpoint
no effect
Not recorded as a finding: the intervention held more than the compound
Compared to baseline the mean number of pockets >4 mm per subject was significantly lower with both protocols (p < 0.001); the difference between groups was not significant (primary outcome).
PMID 25041441 · one of two readings recorded this
number of sites with PD >4 mm per patient
no effect
n sites with PD >4 mm | 4.6 (5.6) | 4.8 (5.2) | n.s.
PMID 25041441 · one of two readings recorded this
number of sites with PD >4 mm per patient
no effect
n sites with PD >4 | 3.6 (5.8) | 3.9 (6.2) | n.s.
PMID 25041441 · one of two readings recorded this
operator time for subgingival debridement of all sites >4 mm
hand-piece back, was 1.5 ± 1.4 min per person
PMID 25041441 · one of two readings recorded this
operator time for subgingival debridement of all sites >4 mm
the control side was, 1.7 ± 1.5 min
PMID 25041441 · one of two readings recorded this
P. gingivalis (PG) study sites >100,000 cells/ml
no effect
PG >1000; >100,000 | 37; 14 | 37; 12 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. gingivalis (PG) study sites >100,000 cells/ml
no effect
PG >1000; >100,000 | 33; 9 | 34; 10 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. gingivalis (PG) study sites >1000 cells/ml
no effect
PG >1000; >100,000 | 37; 14 | 37; 12 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. gingivalis (PG) study sites >1000 cells/ml
no effect
PG >1000; >100,000 | 33; 9 | 34; 10 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. intermedia (PI) study sites >100,000 cells/ml
no effect
PI >1000; >100,000 | 20; 8 | 14; 6 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. intermedia (PI) study sites >100,000 cells/ml
no effect
PI >1000; >100,000 | 17; 4 | 11; 4 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. intermedia (PI) study sites >1000 cells/ml
no effect
PI >1000; >100,000 | 20; 8 | 14; 6 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. intermedia (PI) study sites >1000 cells/ml
no effect
PI >1000; >100,000 | 17; 4 | 11; 4 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. micra (PM) study sites >100,000 cells/ml
no effect
PM >1000; >100,000 | 44; 19 | 49; 23 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. micra (PM) study sites >100,000 cells/ml
no effect
PM >1000; >100,000 | 41; 19 | 41; 16 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. micra (PM) study sites >1000 cells/ml
no effect
PM >1000; >100,000 | 44; 19 | 49; 23 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
P. micra (PM) study sites >1000 cells/ml
no effect
PM >1000; >100,000 | 41; 19 | 41; 16 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
pain during treatment (VAS 1 to 100 mm), between-arm difference
decreases, p = 0.004
air-polishing was statistically significant (p = 0.004)
PMID 25041441 · one of two readings recorded this
pain during treatment (VAS 1 to 100 mm)
on a VAS from 1 to 100 mm, was 20.4 ± 21.7 mm for the test and
PMID 25041441 · one of two readings recorded this
pain during treatment (VAS 1 to 100 mm)
48.6 ± 29.2 mm for the control treatment
PMID 25041441 · one of two readings recorded this
persisting pockets with probing depth >4 mm at 12 months (primary), probing depth, bleeding on probing, recession, root hypersensitivity VAS, treatment pain VAS, and six subgingival bacteria by qPCR, test side subgingival air-polishing versus control side ultrasonic debridement
p = 0.004, n = 50
Not recorded as a finding: the intervention held more than the compound
The difference in favour of air-polishing was statistically significant (p = 0.004).
PMID 25041441 · one of two readings recorded this
plaque index (PlI)
no effect
PlI, score 0–3 | 0.4 (0.2) | 0.4 (0.2) | n.s.
PMID 25041441 · one of two readings recorded this
plaque index (PlI)
no effect
PlI, score 0–3 | 0.3 (0.1) | 0.3 (0.1) | n.s.
PMID 25041441 · one of two readings recorded this
probing depth (PD), deepest study site
unclear, p = 0.003
PD, mm | 5.2 (0.4) | 5.4 (0.6) | 0.003
PMID 25041441 · one of two readings recorded this
probing depth (PD), deepest study site
no effect
PD, mm | 4.5 (1.0) | 4.4 (1.1) | n.s.
PMID 25041441 · one of two readings recorded this
probing depth (PD)
no effect
PD, mm | 2.8 (0.3) | 2.8 (0.3) | n.s.
PMID 25041441 · one of two readings recorded this
probing depth (PD)
no effect
PD, mm | 2.8 (0.5) | 2.7 (0.5) | n.s.
PMID 25041441 · one of two readings recorded this
root hypersensitivity, deepest study site
no effect
Root hypersensitivity, mm VAS | 22.2 (27.4) | 21.2 (21.2) | n.s.
PMID 25041441 · one of two readings recorded this
root hypersensitivity, deepest study site
no effect
Root hypersensitivity, mm VAS | 21.3 (23.0) | 16.6 (17.8) | n.s.
PMID 25041441 · one of two readings recorded this
T. denticola (TD) study sites >100,000 cells/ml
no effect
TD >1000; >100,000 | 42; 22 | 42; 27 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
T. denticola (TD) study sites >100,000 cells/ml
no effect
TD >1000; >100,000 | 36; 21 | 38; 17 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
T. denticola (TD) study sites >1000 cells/ml
no effect
TD >1000; >100,000 | 42; 22 | 42; 27 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
T. denticola (TD) study sites >1000 cells/ml
no effect
TD >1000; >100,000 | 36; 21 | 38; 17 | n.s.; n.s.
PMID 25041441 · one of two readings recorded this
bacterial species detectable in the pocket sulcus (Maximo 2009, bicarbonate air-abrasive)
decreases
The authors reported a significant reduction of a number of bacterial species detectable in the pocket sulcus
PMID 26065025 · one of two readings recorded this
baseline probing depth at implant 2.5 (case report)
The clinical assessment allowed finding a probing depth of 14 mm mesial/circumferentially to 2.5 with bleeding
PMID 26065025 · one of two readings recorded this
clinical parameters and inflammatory cytokines (prospective study of 20 implants, bicarbonate air-abrasive)
decreases
At 3 months, all clinical parameters improved as the presence of inflammatory cytokines reduced
PMID 26065025 · one of two readings recorded this
gingival index and probing depth (Toma, glycine powder air-polishing)
decreases
Gingival index and probing depth significantly improved in cases treated with glycine powder
PMID 26065025 · one of two readings recorded this
implant failures after follow-up (Behneke 2000, bicarbonate air-polishing with GBR)
unclear
After three years of follow-up, two failures were reported
PMID 26065025 · one of two readings recorded this
implants and patients treated (Behneke 2000)
n = 25
Behneke and coworkers reported data on 25 implants in 17 patients with signs and symptoms of peri-implantitis
PMID 26065025 · one of two readings recorded this
postsurgical complications (case report)
no effect
No complications occurred in the postsurgical period
PMID 26065025 · one of two readings recorded this
stability of bone graft and reosseointegration (case report)
unclear
Both clinical and radiographic examination confirmed a substantial stability of bone graft that allowed hypothesizing the reosseointegration of the implant affected by peri-implantitis
PMID 26065025 · one of two readings recorded this
total amount of TNF-a (case series 2009, sodium carbonate air-powder)
decreases
Moreover, the total amount of TNF-a significantly reduced over time
PMID 26065025 · one of two readings recorded this
bone sounding (BS) at baseline
no effect, p = 0.222
BS base (mm) | 7.00 ± 0.96 | 7.27 ± 0.82 | 0.222
PMID 32839833 · one of two readings recorded this
bone sounding (BS)
no effect, p = 0.916
12 m (mm) | 4.00 ± 0.94S | 4.04 ± 0.75S | 0.916
PMID 32839833 · one of two readings recorded this
bone sounding (BS)
no effect, p = 0.422
6 m (mm) | 4.14 ± 0.72S | 3.88 ± 0.94S | 0.422
PMID 32839833 · one of two readings recorded this
bone sounding gain (ΔBS)
no effect, p = 0.71
ΔBS base-12 m (mm) | 3.11 ± 1.16 | 3.21 ± 0.75 | 0.710
PMID 32839833 · one of two readings recorded this
bone sounding gain (ΔBS)
no effect, p = 0.247
ΔBS base-6 m (mm) | 2.86 ± 1.17 | 3.42 ± 1.26 | 0.247
PMID 32839833 · one of two readings recorded this
CAL gain (ΔCAL)
no effect, p = 0.266
ΔCAL base-12 m (mm) | 2.50 ± 1.60 | 2.85 ± 1.21 | 0.266
PMID 32839833 · one of two readings recorded this
CAL gain (ΔCAL)
no effect, p = 0.469
ΔCAL base-6 m (mm) | 2.00 ± 1.80 | 2.5 ± 1.26 | 0.469
PMID 32839833 · one of two readings recorded this
clinical attachment level (CAL) at baseline
no effect, p = 0.8
CAL base (mm) | 7.87 ± 1.25 | 8.03 ± 1.54 | 0.800
PMID 32839833 · one of two readings recorded this
clinical attachment level (CAL)
no effect, p = 0.921
12 m (mm) | 5.43 ± 1.91S | 5.38 ± 1.94S | 0.921
PMID 32839833 · one of two readings recorded this
clinical attachment level (CAL)
no effect, p = 0.73
6 m (mm) | 5.86 ± 2.14S | 5.54 ± 2.15S | 0.730
PMID 32839833 · one of two readings recorded this
full-mouth bleeding on probing (BOP) at baseline
no effect, p = 1
BOP base (%) | 13.06 ± 13.97 | 11.94 ± 10.78 | 1.000
PMID 32839833 · one of two readings recorded this
full-mouth bleeding on probing (BOP)
no effect, p = 0.685
12 m (%) | 12.91 ± 12.55 | 14.21 ± 13.42 | 0.685
PMID 32839833 · one of two readings recorded this
full-mouth bleeding on probing (BOP)
no effect, p = 0.381
6 m (%) | 11.83 ± 7.32 | 10.71 ± 6.71 | 0.381
PMID 32839833 · one of two readings recorded this
full-mouth bleeding on probing, gingival bleeding index and full-mouth plaque score, baseline to 6 and 12 months
no effect, p > 0.05
Not recorded as a finding: The only sentence mixes within-arm change over time with the between-group comparison and names the patients, not the compound; full-mouth BOP in a periodontal surgery trial at one tooth is not a clean between-arm contrast
Patients maintained good oral hygiene (FMPS) and low levels of inflammation (BOP; GBI) without statistically significant changes between baseline and 6 or 12 months respectively or between the two treatment groups (p > 0.05) (Table 3).
PMID 32839833 · one of two readings recorded this
full-mouth gingival bleeding index (GBI) at baseline
no effect, p = 0.983
GBI base (%) | 5.57 ± 8.15 | 4.89 ± 6.85 | 0.983
PMID 32839833 · one of two readings recorded this
full-mouth gingival bleeding index (GBI)
no effect, p = 0.666
12 m (%) | 4.92 ± 6.80 | 4.13 ± 5.84 | 0.666
PMID 32839833 · one of two readings recorded this
full-mouth gingival bleeding index (GBI)
no effect, p = 0.123
6 m (%) | 5.54 ± 10.05 | 3.03 ± 7.36 | 0.123
PMID 32839833 · one of two readings recorded this
full-mouth plaque score (FMPS) at baseline
no effect, p = 0.455
FMPS base (%) | 23.34 ± 13.14 | 19.36 ± 13.06 | 0.455
PMID 32839833 · one of two readings recorded this
full-mouth plaque score (FMPS)
no effect, p = 0.356
12 m (%) | 17.57 ± 9.86 | 23.22 ± 14.08 | 0.356
PMID 32839833 · one of two readings recorded this
full-mouth plaque score (FMPS)
no effect, p = 0.299
6 m (%) | 21.85 ± 9.58 | 20.26 ± 16.48 | 0.299
PMID 32839833 · one of two readings recorded this
PD reduction (ΔPD)
no effect, p = 0.24
ΔPD base-12 m (mm) | 3.00 ± 0.96 | 3.38 ± 1.12 | 0.240
PMID 32839833 · one of two readings recorded this
PD reduction (ΔPD)
no effect, p = 0.309
ΔPD base-6 m (mm) | 3.00 ± 0.78 | 3.35 ± 1.11 | 0.309
PMID 32839833 · one of two readings recorded this
pocket closure (PD ≤ 3 mm), percentage of patients
no effect
At 12 months, a comparable percentage of patients showed “pocket closure” (PD ≤ 3 mm): 78.57% (n = 11) in the test group and 76.92% (n = 10) in the control group
PMID 32839833 · one of two readings recorded this
probing depth (PD) and PD reduction, bone sounding, radiographic bone level at 12 months
no effect, p > 0.05
Not recorded as a finding: No node for periodontal probing depth (peri-implant-probing-depth is implant-only), bone sounding or radiographic bone level; the CAL gain sentence names them only in a bracket
There were no statistically significant differences between the two treatment groups neither for CAL gain (p = 0.469/0.266 for 6/12 months) nor for any of the other evaluated clinical parameters at the two evaluated timepoints (p > 0.05, PD, AL, BS).
PMID 32839833 · one of two readings recorded this
probing pocket depth (PD) at baseline
unclear, p = 0.035
PD base (mm) | 6.00 ± 0.00 | 6.23 ± 0.42 | 0.035s
PMID 32839833 · one of two readings recorded this
probing pocket depth (PD)
no effect, p = 0.456
12 m (mm) | 3.07 ± 0.92S | 2.85 ± 0.99S | 0.456
PMID 32839833 · one of two readings recorded this
probing pocket depth (PD)
no effect, p = 0.675
6 m (mm) | 3.00 ± 0.78S | 2.92 ± 0.86S | 0.675
PMID 32839833 · one of two readings recorded this
radiographic bone level (BL) at baseline
no effect, p = 0.917
BL base (mm) | 8.06 ± 2.82 | 7.68 ± 2.01 | 0.917
PMID 32839833 · one of two readings recorded this
radiographic bone level (BL)
no effect, p = 0.433
12 m (mm) | 5.91 ± 2.02S | 6.52 ± 2.41S | 0.433
PMID 32839833 · one of two readings recorded this
radiographic bone level gain (ΔBL)
no effect, p = 0.075
ΔBL (mm) | 2.27 ± 1.52 | 1.30 ± 1.04 | 0.075
PMID 32839833 · one of two readings recorded this
bleeding on probing (BOP, %) at six sites per tooth, manual probe at 0.25 N, 6 months after subgingival instrumentation with or without adjunctive erythritol air-polishing (primary outcome); also PD, CAL, sites with PD >= 5 mm, plaque index, bacterial counts, GCF MMP-8 and IL-1 beta
no effect, no difference between groups, n = 42
Not recorded as a finding: the supporting sentence never names the compound
The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups.
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP), mean PD and attachment level, between groups
no effect
The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP, %) six months after subgingival instrumentation, primary outcome, six-point measurement per tooth with a manual probe at 0.25 N
no effect
Not recorded as a finding: the supporting sentence never names the compound
The means of PD, AL and BOP were significantly improved in both groups three and six months after SI (p < 0.01, p < 0.001) without any difference between the groups.
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP)
decreases
Control group | 27.9 ± 16.5 | 13.9 ± 9.6*** | 12.0 ± 9.2***
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP)
decreases
Control group | 27.9 ± 16.5 | 13.9 ± 9.6*** | 12.0 ± 9.2***
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP)
decreases
Test group | 28.8 ± 31.6 | 13.5 ± 7.5** | 11.5 ± 4.6**
PMID 33372602 · one of two readings recorded this
bleeding on probing (BOP)
decreases
Test group | 28.8 ± 31.6 | 13.5 ± 7.5** | 11.5 ± 4.6**
PMID 33372602 · one of two readings recorded this
IL-1β in gingival crevicular fluid
no effect
The levels of IL-1β did not change, neither in the test nor in the control groups
PMID 33372602 · one of two readings recorded this
interproximal plaque index (API)
no effect
Control group | 24.3 ± 20.7 | 19.7 ± 20.7 | 14.8 ± 9.6*
PMID 33372602 · one of two readings recorded this
interproximal plaque index (API)
decreases
Control group | 24.3 ± 20.7 | 19.7 ± 20.7 | 14.8 ± 9.6*
PMID 33372602 · one of two readings recorded this
interproximal plaque index (API)
no effect
Test group | 16.9 ± 9.7 | 15.9 ± 17.7 | 16.4 ± 14.4
PMID 33372602 · one of two readings recorded this
interproximal plaque index (API)
no effect
Test group | 16.9 ± 9.7 | 15.9 ± 17.7 | 16.4 ± 14.4
PMID 33372602 · one of two readings recorded this
mean clinical attachment level (CAL)
decreases
Control group | 3.52 ± 0.44 | 3.05 ± 0.44*** | 3.02 ± 0.45**
PMID 33372602 · one of two readings recorded this
mean clinical attachment level (CAL)
decreases
Control group | 3.52 ± 0.44 | 3.05 ± 0.44*** | 3.02 ± 0.45**
PMID 33372602 · one of two readings recorded this
mean clinical attachment level (CAL)
decreases
Test group | 3.50 ± 0.45 | 2.94 ± 0.50*** | 2.85 ± 0.42***
PMID 33372602 · one of two readings recorded this
mean clinical attachment level (CAL)
decreases
Test group | 3.50 ± 0.45 | 2.94 ± 0.50*** | 2.85 ± 0.42***
PMID 33372602 · one of two readings recorded this
mean probing depth (PD)
decreases
Control group | 3.08 ± 0.36 | 2.46 ± 0.35*** | 2.30 ± 0.26***
PMID 33372602 · one of two readings recorded this
mean probing depth (PD)
decreases
Control group | 3.08 ± 0.36 | 2.46 ± 0.35*** | 2.30 ± 0.26***
PMID 33372602 · one of two readings recorded this
mean probing depth (PD)
decreases
Test group | 3.14 ± 0.39 | 2.44 ± 0.42*** | 2.23 ± 0.25***
PMID 33372602 · one of two readings recorded this
mean probing depth (PD)
decreases
Test group | 3.14 ± 0.39 | 2.44 ± 0.42*** | 2.23 ± 0.25***
PMID 33372602 · one of two readings recorded this
MMP-8 in gingival crevicular fluid
no effect
The levels of MMP-8 in the GCF decreased in the test group, they were significantly less at six months when compared with baseline, in the control group there was no change
PMID 33372602 · one of two readings recorded this
MMP-8 in gingival crevicular fluid
decreases
The levels of MMP-8 in the GCF decreased in the test group, they were significantly less at six months when compared with baseline, in the control group there was no change
PMID 33372602 · one of two readings recorded this
number of sites with PD ≥ 5 mm, between groups
decreases, p = 0.019
The number of sites with PD ≥ 5 mm was significantly lower in the test group than in the control group after six months (p = 0.019)
PMID 33372602 · one of two readings recorded this
number of sites with PD ≥ 5 mm
decreases
Control group | 27.62 ± 6.54 | 6.54 ± 8.37*** | 3.12 ± 4.02***¶¶
PMID 33372602 · one of two readings recorded this
number of sites with PD ≥ 5 mm
decreases
Control group | 27.62 ± 6.54 | 6.54 ± 8.37*** | 3.12 ± 4.02***¶¶
PMID 33372602 · one of two readings recorded this
number of sites with PD ≥ 5 mm
decreases
Test group | 29.88 ± 15.27 | 4.16 ± 7.68*** | 0.64 ± 1.38***
PMID 33372602 · one of two readings recorded this
number of sites with PD ≥ 5 mm
decreases
Test group | 29.88 ± 15.27 | 4.16 ± 7.68*** | 0.64 ± 1.38***
PMID 33372602 · one of two readings recorded this
Porphyromonas gingivalis counts
decreases
P. gingivalis counts were decreased in the control group at three months versus baseline
PMID 33372602 · one of two readings recorded this
Tannerella forsythia and Treponema denticola counts
decreases
The counts of T. forsythia and T. denticola were found to be reduced at six months versus baseline in the test group
PMID 33372602 · one of two readings recorded this
bleeding on probing (BoP), patient level
decreases, p = 0.001
BoP | 54.2 ± 4.1 | 38.4 ± 4.1 | 35.6 ± 4.1 | 32.3 ± 4.1 | 25.3 ± 4.1 | − 18.7 ± 3.3 | < 0.001 | − 10.3 ± 3.3 | 0.002 | − 28.9 ± 3.3 | < 0.001
PMID 33478480 · one of two readings recorded this
clinical attachment level at furcation sites, 6 and 12 months, erythritol versus ultrasonic/curette
decreases, 0.8 mm difference at 6 months in favour of control (p = 0.032); 0.6 mm at 12 months (p = 0.097), p = 0.032
Not recorded as a finding: the between-arm sentence does not name CAL, so the object cannot be anchored in the quote; the sentences that name CAL are within-arm gains
At 6 months there was a significant between-treatment difference of 0.8 mm (± 0.4) in favor of the control (p = 0.032), a tendency also observed at 12 months (0.6 mm ± 0.4; p = 0.097).
PMID 33478480 · one of two readings recorded this
clinical attachment level at furcation sites, test versus control, 6 and 12 months (primary outcome)
decreases, 0.8 mm (+/- 0.4) at 6 months in favor of control; 0.6 mm (+/- 0.4) at 12 months, p = 0.097
Not recorded as a finding: The only between-arm sentence gives a significant difference favouring control at 6 months and a non-significant tendency at 12 months, with no sentence stating the 12-month absence in words; it also does not name the compound, and CAL level is not the CAL gain node's change-from-baseline quantity
At 6 months there was a significant between-treatment difference of 0.8 mm (± 0.4) in favor of the control (p = 0.032), a tendency also observed at 12 months (0.6 mm ± 0.4; p = 0.097).
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site, between-treatment difference
no effect, p = 0.097
Difference | 0.5 ± 0.4 | 0.221 | 0.8 ± 0.4 | 0.032 | 0.6 ± 0.4 | 0.097 | 0.3 ± 0.2 | 0.107 | − 0.2 ± 0.2 | 0.404 | 0.2 ± 0.2 | 0.448
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site, between-treatment difference
increases, p = 0.032
Difference | 0.5 ± 0.4 | 0.221 | 0.8 ± 0.4 | 0.032 | 0.6 ± 0.4 | 0.097 | 0.3 ± 0.2 | 0.107 | − 0.2 ± 0.2 | 0.404 | 0.2 ± 0.2 | 0.448
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site
no effect, p = 0.119
Test | 5.5 ± 0.4 | 5.2 ± 0.4 | 5.1 ± 0.4 | − 0.3 ± 0.2 | 0.175 | − 0.1 ± 0.2 | 0.502 | − 0.4 ± 0.3 | 0.119
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site
no effect, p = 0.175
Test | 5.5 ± 0.4 | 5.2 ± 0.4 | 5.1 ± 0.4 | − 0.3 ± 0.2 | 0.175 | − 0.1 ± 0.2 | 0.502 | − 0.4 ± 0.3 | 0.119
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site
decreases, p = 0.004
Control | 5.0 ± 0.2 | 4.4 ± 0.3 | 4.5 ± 0.3 | − 0.6 ± 0.1 | < 0.001 | 0.1 ± 0.1 | 0.584 | − 0.5 ± 0.2 | 0.004
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), furcation site
decreases, p = 0.001
Control | 5.0 ± 0.2 | 4.4 ± 0.3 | 4.5 ± 0.3 | − 0.6 ± 0.1 | < 0.001 | 0.1 ± 0.1 | 0.584 | − 0.5 ± 0.2 | 0.004
PMID 33478480 · one of two readings recorded this
clinical attachment level (CAL), patient level
decreases, p = 0.001
CAL | 4.0 ± 0.2 | 3.7 ± 0.2 | 3.6 ± 0.2 | 3.5 ± 0.2 | 3.5 ± 0.2 | − 0.3 ± 0.0 | < 0.001 | − 0.2 ± 0.0 | < 0.001 | − 0.5 ± 0.1 | < 0.001
PMID 33478480 · one of two readings recorded this
furcation-site probing depth, test versus control, 6 and 12 months (primary outcome)
no effect, no significant between-treatment differences
Not recorded as a finding: No node for periodontal probing depth; the sentence is also agentless about the compound
No significant between-treatment differences were observed for any timepoint.
PMID 33478480 · one of two readings recorded this
furcation sites showing BoP
decreases
At baseline, all sites (100%, inclusion criteria) showed BoP, whereas at 6 months the number decreased to 70% and 90%, and at 12 months to 68% and 53% for test and control sites, respectively
PMID 33478480 · one of two readings recorded this
furcation sites showing BoP
decreases
At baseline, all sites (100%, inclusion criteria) showed BoP, whereas at 6 months the number decreased to 70% and 90%, and at 12 months to 68% and 53% for test and control sites, respectively
PMID 33478480 · one of two readings recorded this
furcation sites with visible plaque
At baseline, 63% of the test furcation sites and 53% of the control furcation sites showed visible plaque following staining
PMID 33478480 · one of two readings recorded this
furcation sites with visible plaque
By 6 months, the corresponding observations were 40% and 45%, and at 12 months 50% and 44%
PMID 33478480 · one of two readings recorded this
furcation sites with visible plaque
By 6 months, the corresponding observations were 40% and 45%, and at 12 months 50% and 44%
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site, between-treatment difference
no effect, p = 0.917
Difference | 0.7 ± 8.8 | 0.937 | 2.2 ± 8.8 | 0.804 | − 1.0 ± 9.1 | 0.917 | − 1.5 ± 12.5 | 0.905 | 3.2 ± 12.7 | 0.804 | 1.7 ± 12.7 | 0.897
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site, between-treatment difference
no effect, p = 0.804
Difference | 0.7 ± 8.8 | 0.937 | 2.2 ± 8.8 | 0.804 | − 1.0 ± 9.1 | 0.917 | − 1.5 ± 12.5 | 0.905 | 3.2 ± 12.7 | 0.804 | 1.7 ± 12.7 | 0.897
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site
decreases, p = 0.001
Test | 79.5 ± 7.5 | 57.3 ± 7.5 | 44.0 ± 7.7 | − 22.2 ± 11.0 | 0.044 | − 14.6 ± 11.2 | 0.171 | − 36.7 ± 11.2 | 0.001
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site
decreases, p = 0.044
Test | 79.5 ± 7.5 | 57.3 ± 7.5 | 44.0 ± 7.7 | − 22.2 ± 11.0 | 0.044 | − 14.6 ± 11.2 | 0.171 | − 36.7 ± 11.2 | 0.001
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site
decreases, p = 0.001
Control | 78.8 ± 7.5 | 55.1 ± 7.5 | 45.0 ± 7.7 | − 23.7 ± 7.6 | 0.002 | − 10.6 ± 7.7 | 0.171 | − 34.2 ± 7.7 | < 0.001
PMID 33478480 · one of two readings recorded this
gingival crevicular fluid (GCF) volume, furcation site
decreases, p = 0.002
Control | 78.8 ± 7.5 | 55.1 ± 7.5 | 45.0 ± 7.7 | − 23.7 ± 7.6 | 0.002 | − 10.6 ± 7.7 | 0.171 | − 34.2 ± 7.7 | < 0.001
PMID 33478480 · one of two readings recorded this
P. micra and T. denticola, furcation sites positive >10^5
increases
P. micra and T. denticola displayed a significant increase from baseline to 6 months for both treatments
PMID 33478480 · one of two readings recorded this
plaque, patient level
decreases, p = 0.009
Plaque | 56.1 ± 4.3 | 45.5 ± 4.3 | 46.5 ± 4.5 | 45.6 ± 4.8 | 44.6 ± 5.2 | − 9.6 ± 3.8 | 0.010 | − 1.8 ± 3.8 | 0.629 | − 11.5 ± 4.4 | 0.009
PMID 33478480 · one of two readings recorded this
probing depth of furcation sites and full mouth, periodontal probe PCP UNC 15, six sites per tooth
no effect
Not recorded as a finding: no outcome node for probing depth around natural teeth; peri-implant-probing-depth is implants only. The between-arm sentence is agentless
No significant between-treatment differences were observed for any timepoint.
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site, between-treatment difference
no effect, p = 0.232
Difference | 0.2 ± 0.3 | 0.468 | 0.5 ± 0.4 | 0.192 | 0.4 ± 0.4 | 0.232 | 0.20 ± 0.3 | 0.454 | − 0.0 ± 0.3 | 0.901 | 0.2 ± 0.3 | 0.540
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site, between-treatment difference
no effect, p = 0.192
Difference | 0.2 ± 0.3 | 0.468 | 0.5 ± 0.4 | 0.192 | 0.4 ± 0.4 | 0.232 | 0.20 ± 0.3 | 0.454 | − 0.0 ± 0.3 | 0.901 | 0.2 ± 0.3 | 0.540
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site
decreases, p = 0.001
Test | 4.8 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.4 | − 0.9 ± 0.2 | < 0.001 | − 0.2 ± 0.2 | 0.331 | − 1.0 ± 0.2 | < 0.001
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site
decreases, p = 0.001
Test | 4.8 ± 0.4 | 4.0 ± 0.4 | 3.7 ± 0.4 | − 0.9 ± 0.2 | < 0.001 | − 0.2 ± 0.2 | 0.331 | − 1.0 ± 0.2 | < 0.001
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site
decreases, p = 0.001
Control | 4.6 ± 0.2 | 3.5 ± 0.3 | 3.4 ± 0.3 | − 1.05 ± 0.2 | < 0.001 | − 0.1 ± 0.2 | 0.534 | − 1.2 ± 0.3 | < 0.001
PMID 33478480 · one of two readings recorded this
probing depth (PD), furcation site
decreases, p = 0.001
Control | 4.6 ± 0.2 | 3.5 ± 0.3 | 3.4 ± 0.3 | − 1.05 ± 0.2 | < 0.001 | − 0.1 ± 0.2 | 0.534 | − 1.2 ± 0.3 | < 0.001
PMID 33478480 · one of two readings recorded this
probing depth (PD), patient level
decreases, p = 0.001
PD | 3.2 ± 0.1 | 2.9 ± 0.1 | 2.8 ± 0.1 | 2.7 ± 0.1 | 2.7 ± 0.1 | − 0.4 ± 0.0 | < 0.001 | − 0.2 ± 0.0 | 0.094 | − 0.5 ± 0.1 | < 0.001
PMID 33478480 · one of two readings recorded this
proportion of furcation sites with PD ≤ 4 mm (pocket closure)
increases
For test sites, the proportion of PD ≤ 4 mm (pocket closure) increased from 60.0% at baseline to 65.0% and 79.0% at 6 and 12 months, respectively
PMID 33478480 · one of two readings recorded this
proportion of furcation sites with PD ≤ 4 mm (pocket closure)
increases
For test sites, the proportion of PD ≤ 4 mm (pocket closure) increased from 60.0% at baseline to 65.0% and 79.0% at 6 and 12 months, respectively
PMID 33478480 · one of two readings recorded this
proportion of furcation sites with PD ≤ 4 mm (pocket closure)
increases
A corresponding increase was observed for control sites from 60.0% at baseline to 80.0% and 84.2% at 6 and 12 months
PMID 33478480 · one of two readings recorded this
proportion of furcation sites with PD ≤ 4 mm (pocket closure)
increases
A corresponding increase was observed for control sites from 60.0% at baseline to 80.0% and 84.2% at 6 and 12 months
PMID 33478480 · one of two readings recorded this
proportion of patient-level PD ≤ 4 mm (pocket closure)
increases
The proportion of PD ≤ 4 mm (pocket closure) increased from 87.7% at baseline to 93.1% and 95.1% at 6 and 12 months, respectively
PMID 33478480 · one of two readings recorded this
proportion of patient-level PD ≤ 4 mm (pocket closure)
increases
The proportion of PD ≤ 4 mm (pocket closure) increased from 87.7% at baseline to 93.1% and 95.1% at 6 and 12 months, respectively
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site, between-treatment difference
no effect, p = 0.334
No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site, between-treatment difference
no effect, p = 0.706
No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site, between-treatment difference
no effect, p = 0.523
No significant between-treatment differences were detected at baseline (p = 0.523) or at 6 (p = 0.706) and 12 (p = 0.334) months
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site
Total mean numbers of species present in test and control furcation sites at baseline were 1.95 and 2.25, respectively
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site
Corresponding numbers at 6 and 12 months were 3.10, 3.15 and 2.21, 1.76
PMID 33478480 · one of two readings recorded this
total mean number of bacterial species per furcation site
Corresponding numbers at 6 and 12 months were 3.10, 3.15 and 2.21, 1.76
PMID 33478480 · one of two readings recorded this
treatment discomfort (VAS)
decreases, p = 0.001
the erythritol air-polishing system (13.3) compared with conventional mechanical debridement (13.3 vs. 32.6; p = 0.001)
PMID 33478480 · one of two readings recorded this
active GLP-1 iAUC 0-60 min, 0-180 min and iCmax after erythritol versus placebo
Not recorded as a finding: Node plasma-glp-1 exists, but the sentences give significance with no direction word
Pairwise comparisons revealed statistically significant differences for 10 g erythritol versus placebo, 25 g erythritol versus placebo, 50 g erythritol versus placebo and for 10 versus 50 g erythritol.
PMID 33565706 · one of two readings recorded this
appetite-related sensations
no effect
No effect of erythritol treatment on appetite‐related sensations was found
PMID 33565706 · one of two readings recorded this
blood lipids (total cholesterol, LDL, HDL, triglycerides) and uric acid
no effect
There was no statistically significant increase from baseline in blood lipids (total cholesterol, LDL, HDL and triglycerides) or uric acid within 120 min after 50 g erythritol
PMID 33565706 · one of two readings recorded this
correlation of aGLP-1 iAUC 0-60 min with gastric emptying
decreases
CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)
PMID 33565706 · one of two readings recorded this
correlation of CCK iAUC 0-60 min with gastric emptying
decreases
CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)
PMID 33565706 · one of two readings recorded this
correlation of PYY iAUC 0-60 min with gastric emptying
decreases
CCK, aGLP‐1 and PYY were weakly negatively correlated with gastric emptying (R = −0.266, R = −0.145 and R = −0.427, respectively)
PMID 33565706 · one of two readings recorded this
gastric emptying AUC 0-180 min (13C-sodium acetate breath test)
increases, p = 0.001
AUC (0‐180 min) (dose*min/h) | 1595.6 ± 252.1 | 2048.4 ± 434.1 | 2052.7 ± 485.3 | 2102.5 ± 259.8 |.001 | 1).035 2).061 3).002
PMID 33565706 · one of two readings recorded this
gastric emptying AUC 0-60 min (13C-sodium acetate breath test)
modulates, p = 0.009
AUC (0‐60 min) (dose*min/h) | 896.9 ± 128.1 | 1103.2 ± 185.6 | 1036.9 ± 190.4 | 921.5 ± 107.3 |.009 | 1).026 4).027
PMID 33565706 · one of two readings recorded this
gastric emptying T50%, pairwise
increases
the time needed to empty 50% of the dose was significantly longer for 50 g erythritol versus placebo (76.4 ± 12.1 vs. 55.5 ± 17.2 min)
PMID 33565706 · one of two readings recorded this
gastric emptying T50%, pairwise
increases
and 50 versus 10 g erythritol (76.4 ± 12.1 vs. 59.8 ± 19.5 min)
PMID 33565706 · one of two readings recorded this
gastric emptying T50% (time 50% emptied)
increases, p = 0.005
T50% (time 50% emptied) (min) | 55. 5 ± 17.2 | 59.8 ± 19.5 | 68.1 ± 16.1 | 76.4 ± 12.1 |.005 | 3).038 4).026
PMID 33565706 · one of two readings recorded this
gastric emptying Tmax (13C-sodium acetate breath test)
increases, p = 0.005
Tmax (min) | 19.29 ± 7.3 | 21.25 ± 7.7 | 25.00 ± 7.4 | 41.25 ± 15.8 |.005 | 3).003 4).005 5).019
PMID 33565706 · one of two readings recorded this
plasma aGLP-1 iAUC 0-180 min
increases, p = 0.002
iAUC (0‐180 min) (pmol x min/L) | −43.9 ± 210.2 | 162.3 ± 290.0 | 149.9 ± 297.6 | 396.0 ± 342.3 |.002 | 1).011 2).013 3).001 6).036
PMID 33565706 · one of two readings recorded this
plasma aGLP-1 iAUC 0-60 min
increases, p = 0.002
iAUC (0‐60 min) (pmol x min/L) | 8.0 ± 83.9 | 151.7 ± 114.4 | 235.2 ± 152.0 | 325.4 ± 200.8 |.002 | 1).016 2).001 3).001 5).03
PMID 33565706 · one of two readings recorded this
plasma aGLP-1 iCmax
increases, p = 0.001
iCmax (pmol/L) | 2.4 ± 2.0 | 7.2 ± 4.2 | 9.1 ± 3.4 | 11.5 ± 5.8 | <.001 | 1).001 2)<.001 3)<.001
PMID 33565706 · one of two readings recorded this
plasma aGLP-1 Tmax
no effect
Tmax (min) | 34.3 ± 64.6 | 31.3 ± 28.2 | 30.0 ± 47.4 | 27.5 ± 8.7 | NS
PMID 33565706 · one of two readings recorded this
plasma CCK iAUC 0-180 min
increases, p = 0.004
iAUC (0‐180 min) (pmol x min/L) | −30.6 ± 56.0 | −32.4 ± 142.2 | 29.4 ± 101.1 | 92.9 ± 177.6 |.004 | 2).028 3).007 5).048
PMID 33565706 · one of two readings recorded this
plasma CCK iAUC 0-60 min
increases, p = 0.001
iAUC (0‐60 min) (pmol x min/L) | −1.9 ± 18.2 | 4.4 ± 45.3 | 58.9 ± 53.8 | 129.8 ± 101.9 |.001 | 2).001 3).001 4).016 5).001 6).012
PMID 33565706 · one of two readings recorded this
plasma CCK iCmax
increases, p = 0.011
iCmax (pmol/L) | 0.6 ± 0.5 | 1.5 ± 1.2 | 3.6 ± 2.9 | 4.9 ± 3.7 |.011 | 1).024 2).003 3).002 4).028 5).003
PMID 33565706 · one of two readings recorded this
plasma CCK Tmax
no effect
Tmax (min) | 57.0 ± 62.1 | 21.3 ± 31.6 | 15.0 ± 0.0 | 20.0 ± 7.4 | NS
PMID 33565706 · one of two readings recorded this
plasma cholecystokinin iAUC 0-60 min, 0-180 min and iCmax after 10, 25, 50 g erythritol versus placebo
Not recorded as a finding: Node plasma-cholecystokinin exists, but the sentences say only 'statistically significant difference' with no direction word; direction is carried by the table
Pairwise comparison revealed a statistically significant difference for 25 g erythritol versus placebo, 50 g erythritol versus placebo, 10 versus 25 g erythritol, 10 versus 50 g erythritol and 25 versus 50 g erythritol.
PMID 33565706 · one of two readings recorded this
plasma GIP iAUC 0-180 min
no effect
iAUC (0‐180 min) (pmol x min/L) | −4893.9 ± 5873.0 | −8033.4 ± 5893.7 | −1036.5 ± 17 308.1 | −7006.8 ± 7383.5 | NS
PMID 33565706 · one of two readings recorded this
plasma GIP iAUC 0-60 min
no effect
iAUC (0‐60 min) (pmol x min/L) | −970.9 ± 1440.5 | −1744.9 ± 1872.8 | −3222.6 ± 7365.1 | −1050 ± 1984.4 | NS
PMID 33565706 · one of two readings recorded this
plasma GIP, motilin, insulin and glucagon iAUC, iCmax and iCmin
no effect
Not recorded as a finding: nodes plasma-gip and plasma-glucagon require sampling after a mixed-nutrient drink (glucagon also after an amino-acid preload) and stimulated-postprandial-insulin requires the amino-acid preload; motilin has no node; this trial gave erythritol in water
No effect of erythritol treatment on plasma GIP, motilin, insulin and glucagon concentrations was found: the values of iAUC 0‐60 min, iAUC 0‐180 min, iCmax and iCmin did not show any overall statistically significant differences (GIP/motilin: Figure 1D,E and Table 1; insulin/glucagon: Figure 2B,C and Table 2).
PMID 33565706 · one of two readings recorded this
plasma glucagon iAUC 0-180 min
no effect
iAUC (0‐180 min) (pmol × min/L] | −45.0 ± 294.3 | −73,8 ± 204.3 | −13.4 ± 279.0 | 42.4 ± 237.1 | NS
PMID 33565706 · one of two readings recorded this
plasma glucagon iAUC 0-60 min
no effect
iAUC (0‐60 min) (pmol × min/L] | 8.6 ± 83.6 | 10.0 ± 53.8 | 16.1 ± 105.3 | 11.3 ± 67.4 | NS
PMID 33565706 · one of two readings recorded this
plasma glucose concentration
no effect
Erythritol treatment did not lead to an increase in plasma glucose concentrations
PMID 33565706 · one of two readings recorded this
plasma glucose concentrations after erythritol
Not recorded as a finding: One-sided negation ('did not lead to an increase') is not no_effect, and the glucose nodes require a glucose load or fasting sample
Erythritol treatment did not lead to an increase in plasma glucose concentrations.
PMID 33565706 · one of two readings recorded this
plasma glucose iAUC 0-180 min
no effect
iAUC (0‐180 min) (mmol × min/L) | −8.46 ± 6.72 | −14.3 ± 45.6 | −48.1 ± 93.8 | −29.5 ± 37.2 | NS
PMID 33565706 · one of two readings recorded this
plasma glucose iAUC 0-60 min
no effect
iAUC (0‐60 min) (mmol × min/L) | −3.32 ± 4.56 | −6.56 ± 17.18 | −13.38 ± 29.66 | −8.13 ± 9.99 | NS
PMID 33565706 · one of two readings recorded this
plasma glucose iCmin
decreases, p = 0.015
iCmin (mmol/L] | −0.17 ± 0.08 | −0.41 ± 0.53 | −0.54 ± 0.76 | −0.38 ± 0.24 |.015 | 1).042
PMID 33565706 · one of two readings recorded this
plasma insulin iAUC 0-180 min
no effect
iAUC (0‐180 min) (μmol × min/L) | −31.8 ± 169.8 | −86.5 ± 165.4 | −122.8 ± 197.6 | −80.8 ± 261.7 | NS
PMID 33565706 · one of two readings recorded this
plasma insulin iAUC 0-60 min
no effect
iAUC (0‐60 min) (μmol × min/L) | 0.75 ± 68.0 | −40.5 ± 63.4 | −33.6 ± 72.4 | 0.84 ± 89.4 | NS
PMID 33565706 · one of two readings recorded this
plasma insulin iAUC and iCmax after erythritol versus placebo, plasma motilin, PYY
no effect, no overall statistically significant differences for insulin and motilin
Not recorded as a finding: stimulated-postprandial-insulin requires an intragastric amino-acid preload followed by a mixed drink, not stated here; no node for motilin or PYY
No effect of erythritol treatment on plasma GIP, motilin, insulin and glucagon concentrations was found: the values of iAUC 0‐60 min, iAUC 0‐180 min, iCmax and iCmin did not show any overall statistically significant differences (GIP/motilin: Figure 1D,E and Table 1; insulin/glucagon: Figure 2B,C and Table 2).
PMID 33565706 · one of two readings recorded this
plasma motilin iAUC 0-180 min
no effect
iAUC (0‐180 min) (pg x min/mL) | −5419 ± 8547 | −2381 ± 17 475 | −349 ± 15 857 | 5539 ± 19 957 | NS
PMID 33565706 · one of two readings recorded this
plasma motilin iAUC 0-60 min
no effect
iAUC (0‐60 min) (pg x min/mL) | −750.3 ± 4302.5 | 881 ± 6306 | 2190 ± 6024 | 3143 ± 6268 | NS
PMID 33565706 · one of two readings recorded this
plasma PYY iAUC 0-180 min
increases, p = 0.001
iAUC (0‐180 min) (pmol x min/L) | −3359 ± 4219 | 578 ± 5009 | −42.7 ± 7948 | 15 628 ± 7773 | <.001 | 3).002 5)<.001 6)<.001
PMID 33565706 · one of two readings recorded this
plasma PYY iAUC 0-60 min
increases, p = 0.001
iAUC (0‐60 min) (pmol x min/L) | −238.3 ± 1200.0 | 568.5 ± 1550.5 | 1167.6 ± 1906.7 | 3935.0 ± 2264.0 |.001 | 3).025 5).001 6).024
PMID 33565706 · one of two readings recorded this